Research programme: Therapore-based vaccines - AVANT

Drug Profile

Research programme: Therapore-based vaccines - AVANT

Alternative Names: Therapore®-based vaccines research programme - AVANT

Latest Information Update: 02 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AVANT Immunotherapeutics
  • Class Cancer vaccines; Viral hepatitis vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Cancer; Hepatitis B; Hepatitis C

Most Recent Events

  • 02 Aug 2006 This programme is still in active development
  • 23 Jul 2004 Preclinical trials in Cancer in USA (unspecified route)
  • 23 Jul 2004 Preclinical trials in Hepatitis B prevention in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top